Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The conversion of ribonucleotides to deoxyribonucleotides (through the action of ribonucleotide reductase) requires NADPH as the electron source, therefore, any rapidly proliferating cell needs large quantities of NADPH
Additional research will need to delineate dosing, timing, and safety prior to general use in fertility care
Choose injection site: Abdomen (at least 2 inches from navel), outer thigh, upper outer arm, or buttocksareas with subcutaneous fat layer [7]
This approach adds a few minutes of preparation time upfront but protects the integrity of every subsequent experimental run
These essential elements, not naturally found in our bodies, work tirelessly to restore suppleness and impart a healthy luminosity by deeply moisturizing and enhancing the skin's protective moisture barrier
Multiple organ protection models PLoS ONE Safety Data Safety Profile from Research Preclinical Safety Summary Toxicity (in vitro)None at research doses Dermal applicationExtensively safety-tested Cu deliveryPhysiological levels 50+ year researchNo serious concerns Regulatory & Risk Considerations FDA statusNot approved therapeutically Injectable human dataVery limited Copper overloadTheoretical at high doses Long-term systemicNot studied GHK-Cu has an excellent dermatological safety record in topical applications
